期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

滤泡树突细胞肉瘤序贯发生弥漫大B细胞淋巴瘤:1例报道及机制探讨

Sequential development of follicular dendritic cell sarcoma to diffuse large B-cell lymphoma: one case report and discussion on its possible mechanism
原文传递
导出
摘要 本文报道1例在滤泡树突细胞肉瘤基础上序贯发生弥漫大B细胞淋巴瘤的罕见病例,并由此探讨滤泡树突细胞肉瘤在弥漫大B细胞淋巴瘤发生和发展中的可能作用。推测肿瘤组织微环境变化及肿瘤细胞转分化可能是这种肿瘤转化发生的两种重要机制。 This article reports a rare case of sequential development of follicular dendritic cell sarcoma （FDCS） to diffuse large B-cell lymphoma （DLBCL）, and discusses the possible role of FDCS in facilitatinging genesis and development of DLBCL. It suggests that tumor microenvironment variation and transdifferentiation of tumor cells may be the two important mechanisms for this sequential development.
作者 宾业鸿 蔡正文 刘汉峰
机构地区 广西医科大学第一附属医院肿瘤内科
出处 《肿瘤》 CAS CSCD 北大核心 2014年第8期768-770,共3页 Tumor
关键词 树突状细胞肉瘤 滤泡 淋巴瘤 大B细胞 弥漫性 细胞转分化 肿瘤微环境 Dendritic cell sarcoma, follicular Lymphoma, large B-cell, diffuse Celltransdifferentiation Tumor microenvironment
分类号 R733.4 [医药卫生—肿瘤]
  • 相关文献

参考文献13

  • 1Monda L, Warnke R, Rosai J. A primary lymph node malignancy with features suggestive of dendritic reticulum cell differentiation. A report of 4 cases[J]. Am J Pathol, 1986, 122(3):562-572. 被引量：1
  • 2Grogg KL, Lae ME, Kurtin PJ, et al. Ciusterin expression distinguishes follicular dendritic cell tumors from other dendritic cell neoplasms: report of a novel follicular dendritic cell marker and clinicopathologic data on 12 additional follicular dendritic cell tumors and 6 additional interdigitating dendritic cell tumors[J]. Am J Surg Pathol, 2004, 28(8):988-998. 被引量：1
  • 3Yu H, Gibson JA, Pinkus GS, et al. Podoplanin (D2-40) is a novel marker for follicular dendritic cell tumors[J]. Am J Clin Pathol, 2007, 128(5):776-782. 被引量：1
  • 4Vermi W, Lonardi S, Bosisio D, et al. Identification of CXCL1 3 as a new marker for follicular dendritic cell sarcoma[J].J Pathol, 2008, 216(3):356-364. 被引量：1
  • 5Rezk SA, Nathwani BN, Zhao X, et al. Follicular dendritic cells: origin, function, and different disease-associated patterns[J]. Hum Patholy, 2013, 44(6):937-950. 被引量：1
  • 6Chan JK, Fletcher CD, Nayler SJ, et al. Follicular dendritic cell sarcoma. Clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized[J]. Cancer, 1997, 79(2):294-313. 被引量：1
  • 7Li L, Yoon SO, Fu DD, et al. Novel follicular dendritic cell molecule, 8D6, collaborates with CD44 in supporting lymphomagenesis by a burkitt lymphoma cell line, L3055[J]. Blood, 2004, 104(3):81 5-821. 被引量：1
  • 8Lee CG, Das B, Lin TL, et al. A rare fraction of drug- resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potential[J]. BrJ Haematol, 2012, 158(1 ):79-90. 被引量：1
  • 9Laurent C,Meggetto F,de Paiva G R,解建军(摘译),王敏(摘译),张仁亚(审校).脾脏滤泡树突状细胞肿瘤伴弥漫性大B细胞淋巴瘤[J].临床与实验病理学杂志,2008,24(5):624-624. 被引量：4
  • 10涂梅峰,郑文,林宁晶,张运涛,王小沛,宋玉琴,谢彦,平凌燕,应志涛,朱军.氟达拉滨联合化疗治疗初治滤泡型淋巴瘤的临床观察[J].肿瘤,2011,31(1):58-63. 被引量：2

二级参考文献9

  • 1MORSCHHAUSER F,MOUNIER N,SEBBAN C,et al.Efficacy and safety of the combination of rituximab,fludarabine,and mitoxantrone for rituximab-naive,recurrent/refractory follicular non-Hodgkin lymphoma with high tumor burden:a multicenter phase 2 trial by the Groupe d' Etude des Lymphomes de I' Adulte(GELA)and Groupe Ouest Est des Leucémies et Autres Maladies du Sang(GOELAMS)[J].Cancer,2010,116(18):4299-4308. 被引量：1
  • 2CHESON B D,PFISTNER B,JUWEID M E,et al.Revised response criteria for malignant lymphoma[J].J Clin Oncol,2007,25(5):579-586. 被引量：1
  • 3HAGENBEEK A,EGHBALI H,MONFARDINI S,et al.Phase Ⅲ intergroup study of fludarabine phosphate compared with cyclophosphamide,vincristine,and prednisone chemotherapy in newly diagnosed patients with stage Ⅲand Ⅳ low-grade malignant Non-Hodgkin's lymphoma[J].J Clin Oncol,2006,24(10):1590-1596. 被引量：1
  • 4HOCHSTER H S,OKEN M M,WINTER J N,et al.Phase Ⅰ study of fludarabine plus cyclophosphamide in patients with previously untreated low-grade lymphoma:results and long-term follow-up-a report from the Eastern Cooperative Oncology Group[J].J Clin Oncol,2000,18(5):987-994. 被引量：1
  • 5FLINN I W,BYRD J C,MORRISON C,et al.Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies[J].Blood,2000,96(1):71-75. 被引量：1
  • 6TAM C S,WOLF M,PRINCE H M,et al.Fludarabine,cyclophosphamide,and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-Hodgkin lymphoma[J].Cancer,2006,106(11):2412-2420. 被引量：1
  • 7CZUCZMAN M S,KORYZNA A,MOHR A,et al.Rituximab in combination with fludarabine chemotherapy in low-grade or follicular Lymphoma[J].J Clin Oncol,2005,23(4):694-704. 被引量：1
  • 8FORSTPOINTNER R,DREYLING M,REPP R,et al.The addition of rituximab to a combination of fludarabine,cyclophosphamide,mitoxantrone(FCM)significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphornas:results of a prospective randomized study of the German Low-Grade Lymphoma Study Group[J].Blood,2004,104(10):3064-3071. 被引量：1
  • 9BUSKE C,GISSELBRECHT C,GRIBBEN J,et al.Refining the treatment of follicular lymphorna[J].Leuk Lymphoma,2008,49(Suppl 1):18-26. 被引量：1

共引文献4

肿瘤
2014年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部